Bio-Reference Laboratories' Q4 Revenues Climb 18 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Bio-Reference Laboratories today said that revenues for its fiscal fourth quarter climbed 18 percent year over year, in spite of a reduction in reimbursements.

For the three months ended Oct. 31, Bio-Reference posted $192.2 million in revenues, compared to $163.5 million a year ago, and edging out the consensus Wall Street estimate of $192.0 million.

The clinical laboratory said that revenue per patient inched up to $80.80 from $79.66, while the number of patients served increased to 2,350 from 2,039.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.